RecruitingNot ApplicableNCT06254196

Clinical Trial of Telenursing for Monitoring Supportive Care Needs in Patients With Lung Cancer and Melanoma Candidates for the First Prescription of Targeted Therapies

Randomized Clinical Trial of Telenursing for Monitoring Supportive Care Needs in Patients With Lung Cancer and Melanoma Candidates for the First Prescription of Targeted Therapies

Sponsor

Regina Elena Cancer Institute

Enrollment

40 participants

Start Date

Mar 1, 2024

Study Type

INTERVENTIONAL

Conditions

Melanoma Lung Neoplasm

Summary

Single-center, randomized clinical trial (RCT) with low intervention level (Telenursing), for the monitoring of patients affected by lung cancer and melanoma who are candidates for first prescription with Targeted Therapies. The study population will consist of patients suffering from lung cancer and melanoma. The objective of the study will be to evaluate the effectiveness of a Telenursing intervention, comparing the mean score of the total SCNs scale (Supportive Care Needs) after one month of treatment in the treatment arm and in the control arm. Enrolled patients will then be randomized into two treatment arms: * Arm 1 (Control Group): current clinical practice * Arm 2 (Experimental group): Telenursing intervention.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This Italian study tests whether a telenursing platform — regular phone or video check-ins with nurses — helps patients with lung cancer or melanoma who are starting targeted drug therapy (a type of oral cancer medication) manage their side effects and stay on treatment. The goal is to improve supportive care and quality of life during therapy. **You may be eligible if...** - You are aged 18–75 with lung cancer or melanoma - You are about to start targeted therapy for the first time (not previously treated with this type of drug) - You can understand and speak Italian - You have access to a computer, tablet, or smartphone with internet **You may NOT be eligible if...** - You have a cancer other than lung cancer or melanoma - You have previously received targeted therapy or are currently receiving other cancer treatments (chemo, radiation, or palliative care only) - You have significant cognitive or psychiatric difficulties Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURETelenursing interventions for monitoring Supportive Care Needs

Use of the Intelligence2health platform, data collection forms on Google Forms, and dedicated telephone line for telenursing remote nursing monitoring interventions. Based on the data, nurses will be able to implement patient education interventions aimed at preventing and monitoring healthcare support needs related to treatment.